What can we learn about asthma from studying occupational asthma?

Annals of Allergy, Asthma and Immunology

Volumn 90, Issue 5 SUPPL. 2, 2003, Pages 7-10

  Frew, Anthony J ^a,b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; ALLERGEN;

AIRWAY OBSTRUCTION; ALLERGIC DISEASE; ASTHMA; BRONCHUS HYPERREACTIVITY; CONFERENCE PAPER; GENETIC PREDISPOSITION; HUMAN; IMMUNE RESPONSE; LEARNING; OCCUPATIONAL ASTHMA; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; RISK FACTOR; TISSUE SPECIFICITY; WORK ENVIRONMENT; WORKPLACE; ARTICLE; IMMUNOLOGY; OCCUPATIONAL DISEASE;

ALLERGENS; ASTHMA; HUMANS; IMMUNOGLOBULIN E; OCCUPATIONAL DISEASES;

EID: 0037638870     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61641-9     Document Type: Conference Paper

References (43)

1. Quirce S, Sastre J. Occupational asthma. Allergy. 1998;53: 633-641.
2. Banks DE, Wang ML. Occupational asthma: the big picture. Occup Med. 2000;15:335-358.
3. 1 decline in male working populations. Am Rev Respir Dis. 1992; 146:878-883.
4. Tee R, Cullinan P, Welch J, Burge PS, Newman-Taylor AJ. Specific IgE to isocyanates: a useful diagnostic role in occupational asthma. J Allergy Clin Immunol. 1998;101:709-715.
5. Yoshida K, Suga M, Nishiura Y, Arima K, Yoneda R, et al. Occupational hypersensitivity pneumonitis in Japan: data on a nationwide epidemiological study. Occup Environ Med. 1995; 52:570-574.
6. Grammer LC, Shaughnessy MA, Henderson J, Zeiss CR, Kavich DE, et al. A clinical and immunologic study of workers with trimellitic anhydride-induced immunologic lung disease after transfer to low exposure jobs. Am Rev Respir Dis. 1993;148: 54-57.
7. Venables KM, Topping MD, Nunn AJ, Howe W, Newman-Taylor AJ. Immunologic and functional consequences of chemical (tetraphthalic anhydride) induced asthma after four years of avoidance of exposure. J Allergy Clin Immunol. 1987;80:212-218.
8. Curran AD, Burge PS, Wiley K. Clinical and immunological evaluation of workers exposed to glutaraldehyde. Allergy. 1996; 51:826-832.
9. Assoufi BK, Venables KM, Cook A, et al. Outcome of occupational asthma due to platinum salts. Thorax. 1996;51(Suppl): A41.
10. Butcher BT, O'Neil CE, Reed MA, Salvaggio JE, Weill H. Development and loss of toluene diisocyanate reactivity: immunologic, pharmacologic and provocation challenge studies. J Allergy Clin Immunol. 1982;70:231-235.
11. Paggiaro PL, Vagaggini B, Dente FL, Bacci E, Bancalari L, et al. Bronchial hyperresponsiveness and toluene diisocyanate: longterm change in sensitized asthmatic subjects. Chest. 1993; 103:1123-1128.
12. Moscato G, Godnic-Cvar J, Maestrelli P, Malo JL, Burge PS, Coifman R. Statement on self-monitoring of peak expiratory flows in the investigation of occupational asthma. Eur Respir J. 1995;8:1605-1610.
13. Chan-Yeung M. Assessment of asthma in the workplace. Chest. 1995;108:1084-1117.
14. Bernstein DI, Jolly A. Current diagnostic methods for diisocyanate induced occupational asthma. Am J Ind Med. 1999;36: 459-468.
15. Malo JL. The case for confirming occupational asthma: why, how much, how far? J Allergy Clin Immunol. 1993;91:967-970.
16. Perrin B, Cartier A, Ghezzo H, Grammer L, Harris K, et al. Reassessment of the temporal patterns of bronchial obstruction after exposure to occupational sensitizing agents. J Allergy Clin Immunol. 1991;87:630-639.
17. Haselden M, Kay AB, Larche M. Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions. J Exp Med. 1999;189: 1885-1894.
18. Ameille J, Pairon JC, Bayeux MC, Brochard P, Choudat D, et al. Consequences of occupational asthma on employment and financial status: a follow-up study. Eur Respir J. 1997;10: 55-58.
19. Malo JL, Ghezzo H, L'Archeveque J, Lagier F, Perrier B, Cartier A. Is the clinical history a satisfactory means of diagnosing occupational asthma? Am Rev Respir Dis. 1991;143: 528-532.
20. Lemiere C, Cartier A, Dolovich J, Chan-Yeung M, Grammer L, et al. Outcome of specific bronchial responsiveness to occupational agents after removal from exposure. Am J Respir Crit Care Med. 1996;154:329-333.
21. Burge PS. Occupational asthma in electronics workers caused by colophony fumes: follow-up of affected workers. Thorax. 1982;37:348-353.
22. Sayseth V, Kongerud J, Aalen OO, Botten G, Boe J. Bronchial responsiveness decreases in relocated aluminium potroom workers compared with workers who continue their potroom exposure. Int Arch Occup Environ Health. 1995;67:53-57.
23. Malo JL, Cartier A, Ghezzo H, Lafrance M, McCants M, Lehrer SB. Patterns of improvement in spirometry, bronchial hyperresponsiveness and specific IgE antibody levels after cessation of exposure in occupational asthma caused by snow-crab processing. Am Rev Respir Dis. 1988;138:807-812.
24. Chan-Yeung M, MacLean L, Paggiaro PL. Follow-up study of 232 patients with occupational asthma caused by western red cedar (Thuja plicata). J Allergy Clin Immunol. 1987;79: 792-796.
25. Gannon PF, Weir DC, Robertson AS, Burge PS. Health, employment and financial outcomes in workers with occupational asthma. Br J Ind Med. 1993;50:491-496.
26. Chan-Yeung M, Giclas PC, Henson PM. Activation of complement by plicatic acid, the chemical compound responsible for asthma due to western red cedar (Thuja plicata). J Allergy Clin Immunol. 1980;65:333-337.
27. Barker RD, van Tongeren MJ, Harris JM, Gardiner K, Venables KM, Newman-Taylor AJ. Risk factors for sensitisation and respiratory symptoms among workers exposed to acid anhydrides: a cohort study. Occup Environ Med. 1998;55: 684-691.
28. Cartier A, Grammer L, Malo JL, Lagier F, Ghezzo H, et al. Specific serum antibodies against isocyanates: association with occupational asthma. J Allergy Clin Immunol. 1989;84: 507-514.
29. Tee R, Cullinan P, Welch J, Burge PS, Newman-Taylor AJ. Specific IgE to isocyanates: a useful diagnostic role in occupational asthma. J Allergy Clin Immunol. 1998;101:709-715.
30. Chan-Yeung M, Chan H, Tse KS, Salari H, Lam S. Histamine and leukotrienes release in bronchoalveolar fluid during plicatic acid-induced bronchoconstriction. J Allergy Clin Immunol. 1989;84:762-768.
31. Bentley AM, Maestrelli P, Saetta M, Fabbri LM, Robinson DS, et al. Activated T-lymphocytes and eosinophils in the bronchial mucosa in isocyanate-induced asthma. J Allergy Clin Immunol. 1992;89:821-829.
32. Frew AJ, Chan H, Lam S, Chan-Yeung M. Bronchial inflammation in occupational asthma due to western red cedar. Am J Respir Crit Care Med. 1995;151:340-344.
33. Frew AJ, Chan H, Chan-Yeung M. Immunologic studies of the mechanisms of occupational asthma caused by western red cedar. J Allergy Clin Immunol. 1993;92:466-472.
34. Bignon JS, Aron Y, Ju LY, Kopferschmitt MC, Garnier R, et al. HLA class II alleles in isocyanate-induced asthma. Am J Respir Crit Care Med. 1994;149:71-75.
35. Horne C, Quintana PJ, Keown PA, Dimich-Ward H, Chan-Yeung M. Distribution of DRB1 and DQB1 HLA class II alleles in occupational asthma due to western red cedar. Eur Respir J. 2000;15:911-914.
36. Venables KM, Newman-Taylor AJ. Exposure-response relationships in asthma caused by tetrachlorophthalmic anhydride. J Allergy Clin Immunol. 1990;85:55-58.
37. Piirila PL, Nordman H, Keskinen HM, Luukkonen R, Salo SP, et al. Long-term follow-up of hexamethylene diisocyanate-, diphenylmethane diisocyanate-, and toluene diisocyanate-induced asthma. Am J Respir Crit Care Med. 2000;162: 516-522.
38. Paggiaro PL, Bacci E, Paoletti P, Bernard P, Dente FL, et al. Bronchoalveolar lavage and morphology of the airways after cessation of exposure in asthmatic subjects sensitized to toluene diisocyanate. Chest. 1990;98:536-542.
39. Saetta M, Maestrelli P, Turato G, Mapp CE, Milani G, et al. Airway wall remodelling after cessation of exposure to isocyanates in sensitized asthmatic subjects. Am J Respir Crit Care Med. 1995;151:489-494.
40. Maestrelli P, di Stefano A, Occari P, Turato G, Milani G, et al. Cytokines in the airway mucosa of subjects with asthma induced by toluene diisocyanate. Am J Respir Crit Care Med. 1995;151:607-612.
41. Han SJ, Kim JH, Noh YJ, Chang HS, Kim CS, et al. IL-5 downregulates TNF-induced eotaxin mRNA expression in eosinophils: induction of eotaxin mRNA by TNF and IL-5 in eosinophils. Am J Respir Cell Mol Biol. 1999;21:303-310.
42. Hughes JM, Rimmer SJ, Salome CM, Hodge L, Liu-Brennan D, et al. Eosinophilia, IL-5 and TNF-alpha in asthmatic children. Allergy. 2001;56:412-418.
43. Reed CE. The natural history of asthma in adults: the problem of irreversibility. J Allergy Clin Immunol. 1999;103:539-547.